|
1
|
Komotar RJ, Otten ML, Moise G and Connolly
ES Jr: Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma-a critical review. Clin Med Oncol. 2:421–422.
2008.PubMed/NCBI
|
|
2
|
Kleihues P, Burger PC and Scheithauer BW:
The new WHO classification of brain tumours. Brain Pathol.
3:255–268. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wakimoto H, Aoyagi M, Nakayama T, et al:
Prognostic significance of Ki-67 labeling indices obtained using
MIB-1 monoclonal antibody in patients with supratentorial
astrocytomas. Cancer. 77:373–380. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pollack IF: Brain tumors in children. N
Engl J Med. 331:1500–1507. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Soffietti R, Leoncini B and Rudà R: New
developments in the treatment of malignant gliomas. Expert Rev
Neurother. 7:1313–1326. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stupp R, Hegi ME, Gilbert MR and
Chakravarti A: Chemoradiotherapy in malignant glioma: Standard of
care and future directions. J Clin Oncol. 25:4127–4136. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shimono A, Okuda T and Kondoh H:
N-myc-dependent repression of ndr1, a gene identified by direct
subtraction of whole mouse embryo cDNAs between wild type and N-myc
mutant. Mech Dev. 83:39–52. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Okuda T and Kondoh H: Identification of
new genes ndr2 and ndr3 which are related to Ndr1/RTP/Drg1 but show
distinct tissue specificity and response to N-myc. Biochem Biophys
Res Commun. 266:208–215. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin TM and Chang C: Cloning and
characterization of TDD5, an androgen target gene that is
differentially repressed by testosterone and dihydrotestosterone.
Proc Natl Acad Sci USA. 94:4988–4993. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou D, Salnikow K and Costa M: Cap43, a
novel gene specifically induced by Ni2+ compounds. Cancer Res.
58:2182–2189. 1998.PubMed/NCBI
|
|
11
|
Kokame K, Kato H and Miyata T:
Homocysteine-respondent genes in vascular endothelial cells
identified by differential display analysis. GRP78/BiP and novel
genes. J Biol Chem. 271:29659–29665. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kurdistani SK, Arizti P, Reimer CL, Sugrue
MM, Aaronson SA and Lee SW: Inhibition of tumor cell growth by
RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res.
58:4439–4444. 1998.PubMed/NCBI
|
|
13
|
Qu X, Zhai Y, Wei H, et al:
Characterization and expression of three novel
differentiation-related genes belong to the human NDRG gene family.
Mol Cell Biochem. 229:35–44. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou RH, Kokame K, Tsukamoto Y, Yutani C,
Kato H and Miyata T: Characterization of the human NDRG gene
family: A newly identified member, NDRG4, is specifically expressed
in brain and heart. Genomics. 73:86–97. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM and
Pardee AB: Drg-1 as a differentiation-related, putative metastatic
suppressor gene in human colon cancer. Cancer Res. 60:749–755.
2000.PubMed/NCBI
|
|
16
|
van Belzen N, Dinjens WN, Diesveld MP, et
al: A novel gene which is up-regulated during colon epithelial cell
differentiation and down-regulated in colorectal neoplasms. Lab
Invest. 77:85–92. 1997.PubMed/NCBI
|
|
17
|
Bandyopadhyay S, Pai SK, Hirota S, et al:
PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in
prostate and breast cancer. Cancer Res. 64:7655–7660. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bandyopadhyay S, Pai SK, Gross SC, et al:
The Drg-1 gene suppresses tumor metastasis in prostate cancer.
Cancer Res. 63:1731–1736. 2003.PubMed/NCBI
|
|
19
|
Ando T, Ishiguro H, Kimura M, et al:
Decreased expression of NDRG1 is correlated with tumor progression
and poor prognosis in patients with esophageal squamous cell
carcinoma. Dis Esophagus. 19:454–458. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun B, Chu D, Li W, et al: Decreased
expression of NDRG1 in glioma is related to tumor progression and
survival of patients. J Neurooncol. 94:213–219. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kokame K, Kato H and Miyata T:
Nonradioactive differential display cloning of genes induced by
homocysteine in vascular endothelial cells. Methods. 16:434–443.
1998. View Article : Google Scholar
|
|
22
|
Taketomi Y, Sugiki T, Saito T, et al:
Identification of NDRG1 as an early inducible gene during in vitro
maturation of cultured mast cells. Biochem Biophys Res Commun.
306:339–346. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Agarwala KL, Kokame K, Kato H and Miyata
T: Phosphorylation of RTP, an ER stress-responsive cytoplasmic
protein. Biochem Biophys Res Commun. 272:641–647. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Piquemal D, Joulia D, Balaguer P, Basset
A, Marti J and Commes T: Differential expression of the
RTP/Drg1/Ndr1 gene product in proliferating and growth arrested
cells. Biochim Biophys Acta. 1450:364–373. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gómez-Casero E, Navarro M,
Rodríguez-Puebla ML, et al: Regulation of the
differentiation-related gene Drg-1 during mouse skin
carcinogenesis. Mol Carcinog. 32:100–109. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bandyopadhyay S, Pai SK, Hirota S, et al:
Role of the putative tumor metastasis suppressor gene Drg-1 in
breast cancer progression. Oncogene. 23:5675–5681. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shah MA, Kemeny N, Hummer A, et al: Drg1
expression in 131 colorectal liver metastases: Correlation with
clinical variables and patient outcomes. Clin Cancer Res.
11:3296–3302. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li J and Kretzner L: The growth-inhibitory
Ndrg1 gene is a Myc negative target in human neuroblastomas and
other cell types with overexpressed N- or c-myc. Mol Cell Biochem.
250:91–105. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu P, Cheng H, Roberts TM and Zhao JJ:
Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev
Drug Discov. 8:627–644. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hajduch E, Litherland GJ and Hundal HS:
Protein kinase B (PKB/Akt) - a key regulator of glucose transport?
FEBS Lett. 492:199–203. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gesbert F, Sellers WR, Signoretti S, Loda
M and Griffin JD: BCR/ABL regulates expression of the
cyclin-dependent kinase inhibitor p27Kip1 through the
phosphatidylinositol 3-kinase/AKT pathway. J Biol Chem.
275:39223–39230. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou BP, Liao Y, Xia W, Spohn B, Lee MH
and Hung MC: Cytoplasmic localization of p21Cip1/WAF1 by
Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat
Cell Biol. 3:245–252. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sciaudone M, Gazzerro E, Priest L, Delany
AM and Canalis E: Notch 1 impairs osteoblastic cell
differentiation. Endocrinology. 144:5631–5639. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang J, Ma Y, Jiang H, et al:
Overexpression of von Hippel- Lindau protein synergizes with
doxorubicin to suppress hepatocellular carcinoma in mice. J
Hepatol. 55:359–368. 2011. View Article : Google Scholar
|
|
35
|
Li X, Yang Q, Yu H, et al: LIF promotes
tumorigenesis and metastasis of breast cancer through the AKT-mTOR
pathway. Oncotarget. 5:788–801. 2014.PubMed/NCBI
|
|
36
|
Chen Z, Zhang D, Yue F, Zheng M, Kovacevic
Z and Richardson DR: The iron chelators Dp44mT and DFO inhibit
TGF-β-induced epithelial-mesenchymal transition via up-regulation
of N-Myc downstream-regulated gene 1 (NDRG1). J Biol Chem.
287:17016–17028. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stein S, Thomas EK, Herzog B, et al: NDRG1
is necessary for p53-dependent apoptosis. J Biol Chem.
279:48930–48940. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu B, Lin L and Rote NS: Identification of
a stress-induced protein during human trophoblast differentiation
by differential display analysis. Biol Reprod. 61:681–686. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Floryk D and Thompson TC:
Antiproliferative effects of AVN944, a novel inosine
5-monophosphate dehydrogenase inhibitor, in prostate cancer cells.
Int J Cancer. 123:2294–2302. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ulrix W, Swinnen JV, Heyns W and Verhoeven
G: The differentiation-related gene 1, Drg1, is markedly
upregulated by androgens in LNCaP prostatic adenocarcinoma cells.
FEBS Lett. 455:23–26. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Melotte V, Qu X, Ongenaert M, et al: The
N-myc downstream regulated gene (NDRG) family: Diverse functions,
multiple applications. FASEB J. 24:4153–4166. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Niikura N, Iwamoto T, Masuda S, et al:
Immunohistochemical Ki67 labeling index has similar proliferation
predictive power to various gene signatures in breast cancer.
Cancer Sci. 103:1508–1512. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Takawa M, Cho HS, Hayami S, et al: Histone
lysine methyltrans-ferase SETD8 promotes carcinogenesis by
deregulating PCNA expression. Cancer Res. 72:3217–3227. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Afshar G, Jelluma N, Yang X, et al:
Radiation-induced caspase-8 mediates p53-independent apoptosis in
glioma cells. Cancer Res. 66:4223–4232. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
McDowell KA, Riggins GJ and Gallia GL:
Targeting the AKT pathway in glioblastoma. Curr Pharm Des.
17:2411–2420. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Haas-Kogan D, Shalev N, Wong M, Mills G,
Yount G and Stokoe D: Protein kinase B (PKB/Akt) activity is
elevated in glioblastoma cells due to mutation of the tumor
suppressor PTEN/MMAC. Curr Biol. 8:1195–1198. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Choe G, Horvath S, Cloughesy TF, Crosby K,
Seligson D, Palotie A, Inge L, Smith BL, Sawyers CL and Mischel PS:
Analysis of the phosphatidylinositol 3′-kinase signaling pathway in
glioblastoma patients in vivo. Cancer Res. 63:2742–2746.
2003.PubMed/NCBI
|
|
48
|
Suzuki Y, Shirai K, Oka K, Mobaraki A,
Yoshida Y, Noda SE, Okamoto M, Suzuki Y, Itoh J, Itoh H, et al:
Higher pAkt expression predicts a significant worse prognosis in
glioblastomas. J Radiat Res (Tokyo). 51:343–348. 2010. View Article : Google Scholar
|
|
49
|
Motwani M, Sirotnak FM, She Y, Commes T
and Schwartz GK: Drg1, a novel target for modulating sensitivity to
CPT-11 in colon cancer cells. Cancer Res. 62:3950–3955.
2002.PubMed/NCBI
|
|
50
|
Nakada M, Okada Y and Yamashita J: The
role of matrix metal-loproteinases in glioma invasion. Front
Biosci. 8:e261–e269. 2003. View
Article : Google Scholar
|
|
51
|
Bolteus AJ, Berens ME and Pilkington GJ:
Migration and invasion in brain neoplasms. Curr Neurol Neurosci
Rep. 1:225–232. 2001. View Article : Google Scholar
|
